Payer Account Management & Trade Lead

How You Will Achieve More with Intellia:

We are seeking an experienced and strategic Payer Account Management and Trade Sr. Dir to lead our efforts in building capabilities for the upcoming launch of a groundbreaking gene-editing therapy. This role will be pivotal in establishing payer partnerships, creating a robust distribution strategy, and optimizing access channels to ensure the therapy reaches patients in need. The successful candidate will be responsible for developing and executing an integrated account management and trade strategy that positions our gene-editing therapy for commercial success from day one.  This role will report to the VP, Market Access & Patient Services.  The position will lead a payer account and trade team.

Responsibilities:

• Launch Strategy Development: Design and execute a comprehensive payer account management and trade strategy to support the successful launch of our gene-editing therapy, with a focus on building infrastructure, relationships, and processes to support rapid market access.

• Payer Account Management: Establish and strengthen high-impact relationships with national and regional payers, PBMs, and other stakeholders to secure favorable coverage and reimbursement for the gene-editing therapy, including the development of innovative access and reimbursement models tailored to gene therapies.

• Trade Infrastructure & Operations: Build and oversee trade operations, including partnerships with specialty pharmacies, wholesalers, and distribution networks, to establish seamless distribution and delivery channels for gene-editing therapy.

• Market Access & Reimbursement Readiness: Work closely with Market Access, Government Affairs, and Pricing teams to design and implement payer engagement strategies, reimbursement pathways, and pricing frameworks that support product access and address payer-specific needs for gene-editing therapies.

• Contract Negotiation & Implementation: Contribute to the development, and lead the implementation, of innovative/ value-based contracting as needed to support therapy acceptance with key stakeholders.

• Capability Building: Develop and implement scalable account management and trade processes, SOPs, systems, channel design, vendor selection, and resources to support the gene-editing therapy launch and future expansion, ensuring the team is prepared to meet the unique challenges of gene editing in the healthcare landscape.

• Team Leadership: Build and lead a high-performing Payer Account Management and Trade team, fostering a culture of collaboration, accountability, and launch-readiness to meet ambitious goals.

• Stakeholder Collaboration: Partner closely with internal stakeholders, including Sales, Marketing, Medical Affairs, and Compliance, to align on launch objectives, share insights, and support cross-functional launch success.

• Data-Driven Insights: Leverage payer insights, market data, and performance metrics to continuously refine account management and trade strategies, ensuring flexibility and responsiveness to evolving market dynamics during and after the launch.

• Compliance & Ethical Standards: Ensure all payer engagement, trade, and distribution activities are conducted in compliance with industry regulations, company policies, and ethical standards, particularly regarding innovative gene-editing therapies.

About You:

• Proven success in designing and executing US launch strategies for high-impact therapies, with deep knowledge of payer engagement, reimbursement, and trade dynamics.

• Strong relationships with national and regional payers, PBMs, specialty pharmacies, and distribution networks.

• Exceptional strategic and operational skills, with a demonstrated ability to build infrastructure and lead market access and trade operations for new product launches.

• Strong leadership and team development skills, with experience building and leading high-performing teams in high-stakes, fast-paced environments.

• Excellent communication and relationship-building abilities, with a proven track record of influencing key stakeholders and collaborating effectively across functions.

• A commitment to ethical standards and patient-centered approaches, particularly in the context of gene-editing therapies.

• Ability to work effectively in a fast-paced, growth-oriented environment with a commitment to addressing the unique challenges of gene editing therapies.

• Bachelor’s degree in business, life sciences, or a related field; advanced degree (MBA, PharmD) preferred.

• 8+ years of experience in payer account management, trade, or market access within the pharmaceutical or biotechnology industry, with a strong preference for experience in launching gene or cell therapies, gene-editing therapies, or specialty therapies.

#LI-Remote

#LI-SV1

Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.